Showing results (101-110 of 156) with videos related to
Sort By:
Pageof 16
Current Oncology (Toronto, Ont.)|October 27, 2022
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II TrialDavide Franceschini, Tiziana Comito, Anna Di Gallo, et al.Journal of Cancer Research and Clinical Oncology|June 6, 2023
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)Ciro Franzese, Veronica Vernier, Davide Franceschini, et al.Oncotarget|July 28, 2016
Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected diseaseDavide Franceschini, Fiorenza De Rose, Antonella Fogliata, et al.The British Journal of Radiology|February 22, 2023
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factorsDavide Franceschini, Maria Ausilia Teriaca, Luciana Di Cristina, et al.The British Journal of Radiology|January 12, 2018
Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective seriesFiorenza De Rose, Antonella Fogliata, Davide Franceschini, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 24, 2020
Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapyMauro Loi, Davide Franceschini, Luca Dominici, et al.Journal of Cancer Research and Clinical Oncology|March 5, 2017
Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumoursDavide Franceschini, Luca Cozzi, Fiorenza De Rose, et al.Cancers|August 12, 2023
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study GroupGiulia Marvaso, Federico Mastroleo, Giulia Corrao, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 20, 2025
Where is clinical research in radiation oncology going? a snapshot from Lombardy, Italy-a study endorsed by AIRO LombardiaMattia Zaffaroni, Maria Giulia Vincini, Stefano Arcangeli, et al.Cancer|October 27, 2011
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancerLorenzo Livi, Icro Meattini, Calogero Saieva, et al.Pageof 16